C07C 69/732
Of unsaturated hydroxy carboxylic acids
Official title: of unsaturated hydroxy carboxylic acids
C07C69/732 (Of unsaturated hydroxy carboxylic acids) appears on 579 US grants and 470 published applications in this corpus.
Search patents in C07C- Granted patents
- 579
- Published applications
- 470
- Assignees
- 361
- Inventors
- 1,526
- Latest grant
- 7 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 2 | 0 |
| 1979 | 0 | 0 |
| 1980 | 2 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 3 | 0 |
| 1984 | 1 | 0 |
| 1985 | 2 | 0 |
| 1986 | 5 | 0 |
| 1987 | 6 | 0 |
| 1988 | 3 | 0 |
| 1989 | 3 | 0 |
| 1990 | 6 | 0 |
| 1991 | 9 | 0 |
| 1992 | 23 | 0 |
| 1993 | 13 | 0 |
| 1994 | 12 | 0 |
| 1995 | 24 | 0 |
| 1996 | 24 | 0 |
| 1997 | 36 | 0 |
| 1998 | 15 | 0 |
| 1999 | 14 | 0 |
| 2000 | 21 | 0 |
| 2001 | 14 | 3 |
| 2002 | 12 | 17 |
| 2003 | 17 | 23 |
| 2004 | 15 | 24 |
| 2005 | 7 | 19 |
| 2006 | 12 | 16 |
| 2007 | 10 | 16 |
| 2008 | 12 | 20 |
| 2009 | 16 | 26 |
| 2010 | 20 | 19 |
| 2011 | 10 | 20 |
| 2012 | 13 | 20 |
| 2013 | 17 | 17 |
| 2014 | 18 | 20 |
| 2015 | 17 | 21 |
| 2016 | 16 | 19 |
| 2017 | 12 | 20 |
| 2018 | 14 | 18 |
| 2019 | 21 | 26 |
| 2020 | 21 | 24 |
| 2021 | 16 | 15 |
| 2022 | 8 | 14 |
| 2023 | 4 | 14 |
| 2024 | 10 | 18 |
| 2025 | 13 | 10 |
| 2026 | 7 | 11 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Polymeric biomaterials derived from phenolic monomers and their medical uses7 Jul 2026US 12,674,024 B2Rutgers, The State University of New Jersey
- Industrial method for simultaneously preparing Stevia rebaudiana chlorogenic acid and stevioside9 Jun 2026US 12,649,758 B2Chenguang Biotech Group Co., Ltd.
- Combination product comprising dicycloplatin and preparation method and use thereof26 May 2026US 12,637,487 B2Medoncare Pharmaceutical Co., Ltd.
- Enol ether properfume12 May 2026US 12,624,309 B2Firmenich SA
- Compositions and methods for inhibiting blood cancer cell growth21 Apr 2026US 12,605,352 B2University of New Brunswick
- Processes of producing volixibat and analogs thereof24 Sep 2026US 2026/0285895 A1Mirum Pharmaceuticals, Inc.
- Hydroxyphenyl propanoate compounds for tumour immunotherapy, compositions and uses thereof17 Sep 2026US 2026/0272865 A1
- Endocannabinoid ligands and related analogs13 Aug 2026US 2026/0234099 A1Northeastern University
- Novel anti-senescence compounds9 Jul 2026US 2026/0191812 A1Vitexia Aps
- Indene compounds, pharmaceutical compositions thereof, and their therapeutic applications2 Jul 2026US 2026/0184663 A1NucMito Pharmaceuticals Co. Ltd.
Most cited
By later US patents
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Retroviral protease inhibiting compounds109US 5,354,866 AAbbott Laboratories · 1994
- Phosphorous prodrugs and therapeutic delivery systems using same102US 5,627,165 ADrug Innovation & Design, Inc. · 1997
- Retroviral protease inhibiting compounds94US 5,541,206 AAbbott Laboratories · 1996
- Lipoxin compounds73US 5,441,951 AThe Brigham and Women S Hospital, Inc. · 1995